Loading provider…
Loading provider…
Pulmonary Disease Physician in West Hollywood, CA
NPI: 1285726216Primary Practice Location
CEDARS-SINAI MEDICAL CENTER
8700 Beverly Blvd, Los Angeles, CA
Primary Employer
Cedars-Sinai Medical Care Foundation
cedars-sinai.org
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1976 - 2026
CA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Pulmonary Disease
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1975
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Pulmonary Disease and Critical Care Medicine
1978 - 1980
Residency • Internal Medicine
1975 - 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 665 | 1,207 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 658 | 1,047 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 288 | 378 |
| 4 | 95012Measurement of inhaled nitric oxide gas | 165 | 165 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 113 | 113 |
Authors: Michael Littner, Matthew Conolly, Donald Tashkin
Journal: J Allergy Clin Immunol
Spinal Aspergillus Abscess in a Patient with Bronchocentric Granulomatosis
Authors: Collier, J, Wolfe, R, Lerner, R, Nathan, S, Mohsenifar, Z
Journal: J Intensive Care Med
Authors: Matthew Conolly, Donald Tashkin
Journal: J Allergy Clin Immunol
Lead Sponsor: Suven Life Sciences Limited
Intervention / Treatment: DRUG: Placebo, DRUG: SUVN-G3031
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab, DRUG: Levalbuterol/Levosalbutamol, DRUG: Oral corticosteroid therapy (prednisone/prednisolone), DRUG: Inhaled corticosteroid (ICS) therapy, DRUG: Albuterol/Salbutamol